CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

Livanova to lay off 137 people at Pittsburgh facility

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Livanova will lay off up

February 9, 2024

Four more health care workers reported illnesses after caring for bird flu case in Missouri

An investigation into the still unexplained human H5N1 bird flu infection in Missouri has turned up four additional health care workers who developed mild respiratory

September 27, 2024

Investigating risks of postpartum hemorrhage treatment on future pregnancies

Postpartum hemorrhage (PPH) is a serious condition where a woman experiences significant blood loss after giving birth.

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.